INOVIO to Participate in Upcoming Scientific Conferences
PR Newswire•02/11/2026•16:01 ET
0
Key Highlights
- ➤INOVIO to present rare disease protein replacement therapeutics at November 8 meeting
- ➤INOVIO to present INO-D001 for Hemophilia A on November 12
INOVIO to Participate in Upcoming Scientific Conferences PR Newswire
PLYMOUTH MEETING, Pa., Nov. 2, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in the following scientific conferences:
Get started
Create a free account to read the full story.